Effect of Disopyramide on Left Ventricular Pressure Gradient in Hypertrophic Obstructive Cardiomyopathy in Comparison with Propranolol

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Angiology

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000331979905000410PMID 10225470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy.

  1998cited by this paper
• Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.

  1997cited by this paper
• Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.

  1995cited by this paper
• Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.

  1993cited by this paper
• Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.

  1988cited by this paper
• Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy.

  1988cited by this paper
• Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.

  1988cited by this paper
• Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.

  1985cited by this paper

• Dynamic improvement of an acute exacerbated subaortic pressure gradient after intravenous propranolol and cibenzoline, recorded using a pressure wire: a case report

  2022cites this paper
• Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.

  2010cites this paper
• Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy.

  2003cites this paper
• Effect of Cibenzoline, a Class Ia Antiarrhythmic Agent, on Left Ventricular Diastolic Function in Hypertrophic Cardiomyopathy

  2001cites this paper
• Medical treatment of hypertrophic cardiomyopathy

  2000cites this paper